Mecamylamine Hydrochloride

็›้…ธ็พŽๅŠ ๆ˜Ž

Report date: 2024/09/05 17:24:04
NME

Base Information

Drug NameMecamylamine Hydrochloride
Drug Alias Namemecamylaminum็พŽๅกๆ‹‰ๆ˜Ž็›้…ธ็›mecamilamina็พŽๅŠ ๆ˜Ž็›้…ธ็›็›้…ธ็พŽๅกๆ‹‰ๆ˜Ž +[13]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsDiabetic macular oedemaMenopausal symptomsDevelopmental Disabilities +[12]ย 
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1956/03/01
Country/TerritoryCzechiaUnited StatesUkraine +[7]ย 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTargacept Pharma
China Registration ClassN/A

Develop Information

Active CompaniesPhoenixus AGUniversity Of VermontVanderbilt University Medical Center
Inactive CompaniesYale UniversityThe Ohio State UniversityComentis Inc +[4]ย 
Active IndicationsMenopausal symptomsCognitive DysfunctionHealthy Aging +[4]ย 
Inactive IndicationsDiabetic macular oedemaDevelopmental DisabilitiesAutistic Disorder +[8]ย 

Other Information

ATC CodeC02BB01
Related LinksWikipediaDrugBankKEGG